List of publications

All the publications of the C3M teams.

Export in CSV
Caloric restriction modulates Mcl-1 expression and sensitizes lymphomas to BH3 mimetic in mice.

Authors Meynet O, Zunino B, Happo L, Pradelli LA, Chiche J, Jacquin MA, Mondragón L, Tanti JF, Taillan B, Garnier G, Reverso-Meinietti J, Mounier N, Michiels JF, Michalak EM, Carles M, Scott CL, Ricci JE

Blood Oct 2013

Chondrogenic potential of stem cells derived from adipose tissue: a powerful pharmacological tool.

Authors Roux C, Pisani DF, Yahia HB, Djedaini M, Beranger GE, Chambard JC, Ambrosetti D, Michiels JF, Breuil V, Ailhaud G, Euller-Ziegler L, Amri EZ

Biochemical and biophysical research communications Oct 2013

Vitamin D in pregnancy and early life: the right target for prevention of allergic disease?

Authors Tulic MK

Expert review of clinical immunology Sep 2013

Technical advance: actin CytoFRET, a novel FRET flow cytometry method for detection of actin dynamics in resting and activated T cell.

Authors Larbret F, Dubois N, Brau F, Guillemot E, Mahiddine K, Tartare-Deckert S, Verhasselt V, Deckert M

Journal of leukocyte biology Sep 2013

Postnatal soluble FGFR3 therapy rescues achondroplasia symptoms and restores bone growth in mice.

Authors Garcia S, Dirat B, Tognacci T, Rochet N, Mouska X, Bonnafous S, Patouraux S, Tran A, Gual P, Le Marchand-Brustel Y, Gennero I, Gouze E

Science translational medicine Sep 2013

The emerging role of connexin 43 in testis pathogenesis.

Authors Chevallier D, Carette D, Gilleron J, Segretain D, Pointis G

Current molecular medicine Sep 2013

TNFα-induced lysosomal membrane permeability is downstream of MOMP and triggered by caspase-mediated NDUFS1 cleavage and ROS formation.

Authors Huai J, Vögtle FN, Jöckel L, Li Y, Kiefer T, Ricci JE, Borner C

Journal of cell science Sep 2013

Monosomal karyotype improves IPSS-R stratification in MDS and AML patients treated with Azacitidine.

Authors Cluzeau T, Mounier N, Karsenti JM, Richez V, Legros L, Gastaud L, Garnier G, Re D, Montagne N, Gutnecht J, Gabriel Fuzibet J, Auberger P, Raynaud S, Cassuto JP

American journal of hematology Sep 2013

Recurrent BRAF kinase fusions in melanocytic tumors offer an opportunity for targeted therapy.

Authors Botton T, Yeh I, Nelson T, Vemula SS, Sparatta A, Garrido MC, Allegra M, Rocchi S, Bahadoran P, McCalmont TH, LeBoit PE, Burton EA, Bollag G, Ballotti R, Bastian BC

Pigment cell & melanoma research Aug 2013

The metabolic perturbators metformin, phenformin and AICAR interfere with the growth and survival of murine PTEN-deficient T cell lymphomas and human T-ALL/T-LL cancer cells.

Authors Rosilio C, Lounnas N, Nebout M, Imbert V, Hagenbeek T, Spits H, Asnafi V, Pontier-Bres R, Reverso J, Michiels JF, Sahra IB, Bost F, Peyron JF

Cancer letters Aug 2013